<< Researchers move closer to understanding the basis of a severe epilepsy and mental retardation | Researchers discover brain mechanism involved with interpreting visual signals >>

Molecular finding will help better understand measles and mumps

Published on January 5, 2006 at 5:31 PM · No Comments

A team of Northwestern University researchers has solved the structure of a molecule that controls the ability of viruses of the paramyxovirus family, including the viruses that cause measles, mumps, and many human respiratory diseases, to fuse with and infect human cells.

Determining the structure of this molecule and its role in the viral fusion mechanism may aid the development of drugs and vaccines that target these types of viruses, say the scientists, whose work was funded by the National Institute of General Medical Sciences (NIGMS) and the National Institute of Allergy and Infectious Diseases (NIAID), both parts of the National Institutes of Health (NIH).

Continued on Next page >>

Loyola to launch interdisciplinary Geriatric Fracture ProgramLoyola University Hospital is launching an interdisciplinary Geriatric Fracture Program to reduce ho...
Doctors demonstrate the true impact of vaccinationWith Children Back in School, Doctors Clear up Confusion and Demonstrate the True Impact of Vaccinat...
Balloon Sinuplasty minimally invasive surgery safe for treating chronic sinusitis in childrenA recently published study in the American Journal of Rhinology and Allergy demonstrates Balloon Sin...
New approach to protein misfolding may lead to novel therapies for a number of diseasesIn an encouraging new development, a team led by Scripps Research Institute scientists has restored ...
NIAID creates HIV vaccine discovery branchTo accelerate the translation of basic discoveries about HIV into advances in vaccine design and eva...
Parents follow pediatrician advice on administering MMR vaccinationsNews stories about an allegedly harmful link between the mumps, measles and rubella vaccine and the ...
Biota and MedImmune announce clinical trial for respiratory syncytial virus antiviral drugBiota Holdings Limited and MedImmune Inc. today announced the start of a Phase Ia clinical trial for...
DNA analysis could boost accuracy of thyroid testsBy fine-tuning "fine-needle aspiration" biopsies with a super-fast genetic microarray technology, a ...
Global warming may be reducing respiratory illnessesRising global temperatures over the past two decades may be responsible for a shortened season of a ...
Latin America still not faced a large-scale AIDS epidemicAlthough the risk patterns that favor the expansion of HIV are very widespread, the majority of the ...
China, SARS ourbreak containedChinese authorities have today reported test results confirming that the 53-year-old woman who died ...
New Theory About Alzheimer's DiseaseA group of scientists at The Scripps Research Institute has proposed a new theory about the cause of...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.